Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-26,903
Closed -$572K 240
2019
Q4
$572K Buy
+26,903
New +$597K 0.04% 211
2018
Q4
Sell
-14,196
Closed -$558K 237
2018
Q3
$558K Sell
14,196
-17,708
-56% -$798K 0.04% 218
2018
Q2
$1.57M Buy
+31,904
New +$1.81M 0.08% 226
2017
Q1
Sell
-69,267
Closed -$4.06M 319
2016
Q4
$4.06M Buy
+69,267
New +$3.66M 0.27% 116

Other funds holding ADNT

J. Goldman & Co's ADNT Position: Q1 2020 in Review

J. Goldman & Co sold out of Adient (ADNT) in Q1 2020, closing a stake of 26,903 shares — an estimated $572K sold.

J. Goldman & Co first reported a position in ADNT in Q4 2016 and held it in 4 quarters. The position peaked at $4.06M in Q4 2016. 284 funds tracked by Wall St. Rank hold ADNT as of Q1 2020.

  • J. Goldman & Co reported no remaining Adient position as of Q1 2020 after selling out during the quarter.
  • J. Goldman & Co sold 26,903 Adient shares in Q1 2020, an estimated $572K.
  • J. Goldman & Co first reported a position in Adient in Q4 2016 and held it in 4 quarters.
  • J. Goldman & Co's Adient position peaked at $4.06M in Q4 2016.
  • 284 funds tracked by Wall St. Rank held Adient as of Q1 2020.

Based on J. Goldman & Co's 13F filing for Q1 2020, filed 15 May 2020.